Cargando…
Risk factors for periorbital dermatitis in patients using dorzolamide/timolol eye drops
This study assessed the clinical risk factors for periorbital dermatitis (PD) after using dorzolamide/timolol eye drops in a total of 1282 glaucoma patients. Both the PD(+) group and the PD(−) group were evaluated using clinical data such as age, sex, dosing duration, presence of benzalkonium chlori...
Autores principales: | Kim, Myungjin, Jang, Hyoju, Rho, Seungsoo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8429663/ https://www.ncbi.nlm.nih.gov/pubmed/34504268 http://dx.doi.org/10.1038/s41598-021-97565-0 |
Ejemplares similares
-
Quality of dorzolamide hydrochloride and timolol maleate containing eye drops distributed online
por: Merczel, Sára, et al.
Publicado: (2023) -
Safety and efficacy of switching from dorzolamide 1.0%/timolol maleate 0.5% eye drops to brinzolamide 1.0%/timolol maleate 0.5% eye drops
por: Inoue, Kenji, et al.
Publicado: (2015) -
Comparative study to assess efficacy and safety of brinzolamide1% and timolol0.5% fixed combination eye drops versus dorzolamide2% and timolol0.5% fixed combination eye drops in management of open-angle glaucoma
por: Agarwal, Prerana, et al.
Publicado: (2022) -
Effect of dorzolamide/timolol combination on the visual field in glaucoma
por: Takeda, Sakurako, et al.
Publicado: (2014) -
Comparison of Latanoprost/Timolol with Carbonic Anhydrase Inhibitor and Dorzolamide/Timolol with Prostaglandin Analog in the Treatment of Glaucoma
por: Inoue, Kenji, et al.
Publicado: (2014)